AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 294: E521-E529, 2008. First published December 26, 2007; doi:10.1152/ajpendo.00590.2007
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/3/E521    most recent
00590.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paglialunga, S.
Right arrow Articles by Cianflone, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paglialunga, S.
Right arrow Articles by Cianflone, K.

Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice

Sabina Paglialunga,1,2 Alexandre Fisette,2 Yafeng Yan,2 Yves Deshaies,2 Jean-Francois Brouillette,1 Marcela Pekna,3 and Katherine Cianflone1,2

1Department of Biochemistry, McGill University, Montreal; 2Centre de Recherche de l'Hôpital Laval, Université Laval, Québec, Canada; and 3Institute of Biomedicine, Sahlgrenska Academy at Göteborg University, Gothenberg, Sweden

Submitted 10 September 2007 ; accepted in final form 21 December 2007

Acylation-stimulating protein (C3adesArg/ASP) is an adipokine that acts on its receptor C5L2 to stimulate triglyceride (TG) synthesis in adipose tissue. The present study investigated ASP levels in mouse models of obesity and leanness and the effect of ASP deficiency in C3 knockout (C3KO) mice on adipose tissue morphology. Plasma ASP levels in wild-type (WT) mice correlated positively with plasma nonesterified fatty acids (NEFA) (R = 0.664, P < 0.001) and total cholesterol (R = 0.515, P < 0.001). Plasma ASP was increased by 85% in obese ob/ob leptin-deficient mice and decreased in lean diacylglycerol acyltransferase 1 (DGAT1) KO mice (–54%) and C/EBP{alpha}β/β transgenic mice (–70%) compared with WT. Mice lacking alternative complement factor B or adipsin (FBKO or ADKO), required for ASP production, were also ASP deficient. Both FBKO and C3KO mice had delayed postprandial TG and NEFA clearance on low-fat (LF) and high-fat (HF) diets, suggesting that lack of ASP, not C3, drives the metabolic phenotype. Adipocyte size distribution in C3KO mice was polarized (increased number of both small and large cells), with decreased adipsin expression (–33% gonadal HF), DGAT1 expression (–31% to –50%) and DGAT activity (–41%). Overall, a reduction/deficiency in ASP is associated with an antiadipogenic state and ASP may provide a target for controlling fat storage.

C3adesArg; complement C3; factor B; diacylglycerol acyltransferase 1; postprandial lipemia



Address for reprint requests and other correspondence: K. Cianflone, Centre de Recherche de l'Hôpital Laval, Y2186, Université Laval, 2725 Chemin Ste-Foy, Québec, Canada G1V 4G5 (e-mail: katherine.cianflone{at}crhl.ulaval.ca)




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. He, C. Atkinson, Z. Evans, J. D. Ellett, M. Southwood, A. Elvington, K. D. Chavin, and S. Tomlinson
A Role for Complement in the Enhanced Susceptibility of Steatotic Livers to Ischemia and Reperfusion Injury
J. Immunol., October 1, 2009; 183(7): 4764 - 4772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.